Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1Phase 1 1

Status

Recruiting 2Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 7Dermatologic 6Breast 6Sarcoma 5Gynecologic 5Genitourinary 5CNS 4Plasma cell 2Thoracic 1

Conditions

Sarcoma 3Hemangiosarcoma 3Sarcoma, Kaposi 1Histiocytoma, Malignant Fibrous 1

Interventions

Radiotherapy 137Cyclophosphamide 132Temozolomide 116Doxorubicin 99Filgrastim 68Ifosfamide 64Gemcitabine 58Etoposide 55Bevacizumab 51Imatinib Mesylate 50fludarabine phosphate 49Irinotecan 46pembrolizumab 45Peripheral Blood Stem Cell Transplantation 45pazopanib 43Magnetic Resonance Spectroscopy 42Methotrexate 40Carboplatin 40Busulfan 40Vincristine 38Surgical Procedures, Operative 37Nivolumab 37Melphalan 37Cisplatin 36Radiation 34Blood Specimen Collection 33Mycophenolic Acid 31Cyclosporine 31Docetaxel 29Trabectedin 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Propranolol × Sarcoma × Clear all
NCT06445166 2026-04-06

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Washington University School of Medicine

Phase 2 Recruiting
25 enrolled
Sarcoma

Sarcoma, Sarcoma, Kaposi

NCT06670976 2025-08-26

Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma

Roswell Park Cancer Institute

Phase 1 Withdrawn
Sarcoma

Sarcoma

NCT04518124 2023-11-22

Propranolol in Angiosarcoma

The Netherlands Cancer Institute

Phase 2 Completed
14 enrolled
Sarcoma

Hemangiosarcoma

NCT05961761 2023-07-27

PROPANE

Herlev and Gentofte Hospital

Phase 2 Recruiting
80 enrolled
Sarcoma

Hemangiosarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT02732678 2016-04-11

PROPAN

Assistance Publique Hopitaux De Marseille

Phase 1/2 Unknown
24 enrolled
Sarcoma

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡